Spatiotemporal effects of IL-4 and designed novel compounds on CNS repair during neu-roinflammation

B15

Nervous tissue regeneration is still an unmet need in Multiple Sclerosis (MS). Our latest discovery of a direct neuronal interleukin-4 (IL-4) receptor signalling pathway, leading to axonal protection and repair during chronic neuroinflammation, set the stage for this proposal. We plan to unravel the en-dogenous source and novel functions of IL-4 and develop our discovery for transfer into the clinic. We designed novel compounds, which we would like to test in different MS models, compare and combine with other treatments, and study in human culture systems to directly unravel regenerative effects on human neurons and test blood brain barrier permeability. The aim is that results from these investigations lead to novel insights into neuroprotection and -regeneration and to clinical translation of our compounds. These questions will be elucidated in more detail:

    1. What is the source and what are the novel functions of IL-4 in the CNS?
    2. How can we translate IL-4 therapy to the clinic? For this purpose we will use in-house designed novel compounds?
    3. How do the compounds act on human neurons? Are they able to cross the blood brain barrier?

Principal Investigators:

Dr. rer. nat. Christina Francisca Vogelaar
Klinik für Neurologie
Mainz
tineke.vogelaar@unimedizin-mainz.de

Univ.-Prof. Dr. med. Frauke Zipp
Klinik für Neurologie
Mainz
frauke.zipp@unimedizin-mainz.de

News

Mon, 20/09/2021
Register now: 1st Symposium inflammation and imaging
When?: from November 2nd to November 4th 2021 Where?: Schloss (seat of the University Administration) Muenster Organizers: Co-operative Research Centres 1009, 1450, Transregio 128, and Clinical Research Unit 342 – together with Interdisciplinary Centre of Clinical Research (IZKF) and Excellence Cluster Cells in Motion (CiM) Registration is open now! More information: here...more
Mon, 09/08/2021
Dietary conjugated linoleic acid links reduced intestinal inflammation to amelioration of CNS autoimmunity
A close interaction between gut immune responses and distant organ-specific autoimmunity including the CNS in multiple sclerosis has been established in recent years. This so-called gut-CNS axis can be shaped by dietary factors, either directly or via indirect modulation of the gut microbiome and its metabolites. Here, SFB 128 PI Luisa Klotz and colleagues report […]...more
Thu, 28/01/2021
BioNTech Publishes Data on Novel mRNA Vaccine Approach to Treat Autoimmune Diseases in Science
BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced the publication of preclinical data on its novel mRNA vaccine approach against autoimmune diseases in the peer-reviewed journal Science. The publication titled “A non-inflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis” co-authored by SFB principal investigator Ari Waisman summarizes the findings on the disease-suppressing effects […]...more